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Table 1. Demographics and baseline characteristics
Age (years) 78,5  7,6
Sex (M) 16 (44,4)
HT (%) 30 (83,3)
DM (%) 9 (25)
COPD (%) 18 (50)
PVD (%) 11 (30,6)
CABG (%) 9 (25)
Logistic Euroscore 36,4  14,3
Euroscore II 10,2  6,0
STS score 7,9  6,2
LVEF (%) 50,412,5
AV Area (cm2) 0,60,1
Peak AV Gradient (mm Hg) 75,714,3
Mean AV Gradient (mm Hg) 49,38,8
PAP (mm Hg) 45,312,6
HT¼Hypertension; DM¼Diabetes Mellitus; COPD¼Chronic Obstructive Pulmonary Disease;
PVD¼Peripheral Vascular Disease; CABG¼Coronary Artery Bypass Graft; LVEF¼Left Ventric-
ular Ejection Fraction; AV¼ Aortic Valve; PAP¼Pulmonary Arterial Pressure; AF¼Atrial Fibril-
lation; BBB¼Bundle Branch Block; PCI¼Percutaneous Coronary Intervention
Table 2. The types and sizes of the bioprotesis implanted and the femoral
access route
CoreValve 26 (%) 7 (19,4)
CoreValve 29 (%) 12 (33,3)
CoreValve 31 (%) 7 (19,4)
Edwards Sapien 23 (%) 1 (2,8)
Edwards Sapien 26 (%) 9 (25)
Percutaneous (Prostar XL) (%) 7 (19,4)
Surgical cut-down (%) 29 (80,6)
Table 3. Complications
Second valve implantation (%) 2 (5,6)
Vascular complication (%) 5 (13,9)
Paravalvular AR (< Mild) (%) 3 (8,3)
Stroke (%) 1 (2,8)
VSD (%) 1 (2,8)
All causes mortality (%) 4 (11,1)
Reversible LBBB (%) 3 (8,3)
Persistant LBBB (%) 5 (13,9)
Permanent Pacemaker 4 (11.1)
AR¼Aortic Regurgitation; LBBB¼Left Bundle Branch Block; VSD¼Ventricular Septal Defect
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Patients with Aortic Stenosis and Coronary Artery Disease on Clinical Outcomes
in Patients Undergoing Transcatheter Aortic Valve Implantation
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Background: Combined surgical aortic valve replacement (SAVR) and coronary
artery bypass grafting (CABG) in patients with aortic stenosis (AS) and concomitant
coronary artery disease (CAD) is associated with increased operative risks. There is
little knowledge on the outcome associated with performing percutaneous coronary
intervention (PCI) in combination with transcatheter aortic valve implantation (TAVI).
Aim of Study: To investigate the outcome of combined TAVI and PCI in high-risk
patients with symptomatic high-grade AS and signiﬁcant CAD.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAMethods: From 1/2008 until 6/2012 338 consecutive patients (79.96.0 years,
logEuroSCORE 1811%) successfully treated with Medtronic CoreValve (n¼183),
Edwards-SAPIEN (n¼146) or Symetis Acurate bioprosthesis (n¼9) were
included in the analysis. 221 patients (66%) had CAD. 66 patients (19.5%, 33 female)
with signiﬁcant CAD underwent combined TAVI and PCI. In 58 patients (group A)
a staged approach of PCI a mean of 139 days prior to subsequent TAVI was chosen.
8 patients (group B) were treated in a single procedure with PCI ﬁrst. 272 patients
underwent only TAVI (group C).
Results: 30 daymortality for patients undergoing TAVI plus PCI was similar to patients
with isolated TAVI (12.1% vs. 9.9%; OR¼1.4, 95% CI 0.6-3.267; p¼0.436). 7 patients
(10.6%) of the TAVI plus PCI group had a periprocedural myocardial infarction
(NSTEMI) and stroke occurred in two patients (4.7%). There were no signiﬁcant
differences between TAVI plus PCI group vs. TAVI only group with regards to vascular
complications and postprocedure acute renal failure. Contrast volume at TAVI
implantation was higher in group B compared to group A patients (25160 vs. 17973
ml; p¼0.022).
Conclusion: CAD is frequent among patients with severe AS undergoing TAVI.
Revascularization with PCI can be safely performed in addition to TAVI either as
a staged or a concomitant intervention in this high-risk patient population.Pediatric Cardiology
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Efﬁcacy of Very Low Dose Prostaglandin E1 in Duct-Dependent Congenital
Heart Disease
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Introduction: Prostaglandin infusion treatment is of vital importance for keeping the
ductus arteriosus patency while waiting for either open surgery or invasive trans-
catheter intervention in duct-dependent congenital heart disease. Our study aimed at
deﬁning the lowest effective prostaglandin (PG) E1 dose in patients with inadequacy
of both pulmonary blood ﬂow and/or blood mixing (Group 1) and those with inad-
equate systemic blood ﬂow (Group 2).
Methods: Patients referred to our center within two weeks from birth following the
diagnosis of duct-dependent congenital heart disease and the start of i.v. prostaglandin
infusion were included in the study. Patients with inadequacy of both pulmonary blood
ﬂow and/or blood mixing (Group 1) and those with inadequate systemic blood ﬂow
(Group 2) were retrospectively evaluated in two separate groups with regard to the PG
E1 starting dose given in the referring facility, the lowest and the highest dose admin-
istered in our center, treatment duration, adverse effects and administered treatment.
Results: Of the 95 patients considered in the study, 69 (72.6%) belonged to Group 1
and 26 (27.3%) to Group 2. No difference between the groups could be detected as to
sex or birth weight (p¼0.95 and 0.42, respectively). A statistically signiﬁcant difference
could not be established for prostaglandin treatment duration, 9,730,81 days in Group
1 and 11.61.05 in Group 2 (p¼0.064). While the prostaglandin starting dose given to
both groups in the referring facility was 0.0670.003 mcg/kg/min, it was reduced after
titration to 0.0390.002 and 0.0810.005 mcg/kg/min, respectively, and this differ-
ence between the two groups was signiﬁcant (p<0.001). The dose administered to
Group 1 while ductus patency was being maintained was 0.00310.0001 compared to
0.00420.005 mcg/kg/min for Group 2, also a statistically signiﬁcant difference
(p<0.001). No adverse effects, including apnea, were observed during PG E1 infusion.
Conclusion: Our ﬁndings indicate that the infusion of prostaglandin at a very low
dose (0.003-0.005 mcg/kg/min) is sufﬁcient to maintain the patency of the ductus
arteriosus. A higher dose of PG E1 may be necessary in patients in patients with
inadequacy of both pulmonary blood ﬂow and/or blood mixing.
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Background and Aim: Congenital corrected transposition of the great arteries is
a group of clinically heterogeneous diseases because of numerous accompanyingLS C37
Table 1. Clinical, anthropometric, and biochemical characteristics
Variables
Low birth
weight group
n ¼68
Normal birth
weight group
n¼60 *p
Birth weight, kg 2.2 (1.6-2.3) 3.3 (3.0-3.8) 0.001
Age, month 12231 12126 0.624
Male, n (%) 36 (53%) 32 (53.4%) 0.468
Weight, kg 32 (17.6 - 55) 33 (18.1 - 54) 0.241
Height, cm 136 (109 -168) 137 (113-172) 0.455
Waist circumference, cm 61 (43 - 85)) 62(40-86) 0.194
Hip circumference, cm 72 (43-93) 73(42-95) 0.174
Body mass index, kg/m2 19 (16-24) 20 (16- 25) 0.544
Fasting glucose, mg/dl 8216 846 0.577
Total cholesterol, mg/dl 16126 16532 0.545
Triglyceride, mg/dl 10176 9351 0.290
LDL, mg/dl 9624 10129 0.542
HDL, mg/dl 5012 4811 0.394
Calcium, mg/dl 9,80.44 9.80.35 0.659
Magnesium, mg/dl 2.040.12 2.080.25 0.196
C-reactive protein, mg/dl 3.34.8 4.45.6 0.593
Hemoglobin, mg/dl 131.1 130.85 0.223
Serum insulin
concentration, mIU/L
6.85.3 8.37.1 0.098
HOMA 1.570.27 1.800.20 0.363
Serum creatinine, mg
/dl
0.80.02 0.750.01 0.648
Data are presentedmeanSD andmedian (minimal-maximal), *Student t test, Mann-Whitney U
test, and chi square. HDL-high density lipoprotein, LDL-lowdensity lipoprotein, Homeostaticmodel
assessment index (HOMA) ¼ (Fasting glucose X Fasting insulin concentration X 0.0555) / 22.5
Table 2. Blood pressures and ultrasound assessment of the carotid IMT and
brachial artery FMD
Low birth
weight group
Normal birth
weight group
O
R
A
L
Sanomalies. In this study, we aimed to conduct retrospective analysis of the data of the
patients who were diagnosed and followed up at our center.
Method: Among 64 patients followed with a diagnosis of congenital corrected
transposition of the great arteries at Pediatric Cardiology Clinic of our hospital
between March 2003 and February 2013, the echocardiographic ﬁndings, cardiac
catheterization ﬁndings of those with an indication, need for a permanent pacemaker,
and surgical methods were analyzed retrospectively.
Results: At admission, the age of the patients ranged between 3 days to 20 years (mean
64.4 months). The gender distribution was found to be 26 (39.6%) female to 38 (59.4%)
male and mean follow-up time was 48 months (1 month to 120 months). Of the patients,
50 (78.1%) had atrial situs solitus, 11 (17.2%) had atrial situs inversus and 25 (39.1%)
had dextrocardia. In addition, 50 (78.1%) patients had L-TGA, 11 (18.8%) had D-TGA,
1 (1.6%) had anteroposterior great arterial relationship, and 1 (%1.6) had side-by-side
great arterial relationship. Large inlet to outlet VSD was found in 21 (32.8%) patients,
while subpulmonic type VSD was found in 18 (28%) patients. Furthermore, 8 (12.5%)
and 35 (54.6%) patients were presentedwith pulmonary atresia and valvular/subvalvular
pulmonary stenosis, respectively.While 5 (7.8%) patients had Ebstein-like systemic AV
valve to be the other most common accompanying anomaly, 26 patients had no
accompanying anomaly. Glenn anastomosis was performed in 12 (18.8%) patients,
conventional repair in 7 (10.9%) patients, Fontan operation in 6 (9.9%) patients, Rastelli
+ hemiMustard procedure in 1 (1.6%) patients, and double switch operation in 1 (1.6%)
patients. Permanent pacemaker implantation was performed in 7 (10.9%) patients due to
the development of complete AV block in the follow-up period. Transcatheter inter-
ventional procedures applied were conduit balloon angioplasty (3; 4.8%), ductal stent
implantation (2; 3.1%), Fontan fenestration closure (1; 1.6%), transcatheter dilatation of
MBT shunt (1; 1.6%), and balloon atrial septostomy (1; 1.6%).
Discussion: In patients with congenital corrected transposition of great arteries,
different surgical procedures and palliative transcatheter interventions may be required
based on the type of the lesion. Accurate determination of associated lesions is of great
importance in the management and lifelong follow-up of these patients.
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Objective: To assess whether endothelial function of the brachial artery and carotid
artery intima-media thickness is normal or impaired in children born at term with low
birth weight.
Methods: The ﬁrst group, the LBW group, was composed of 68 LBW children [32
female and 36 male, between 65 and 168 months old, birth weight 2.1 (1.5-2.4) kg].
The second group, the NBW group, was composed of 60 normal born weight (NBW)
peers [28 female and 32 male, between 66 and 176 months old, birth weight 3.3 (3.0-
3.8) kg]. We compared 2 groups children who were born at term in terms of brachial
artery ﬂow mediated dilatation (FMD) and common carotid intima media thickness.
Results: Anthropometric, clinical, biochemical, cIMT and FMD measurements are
shown in Table 1. There was signiﬁcant difference in terms of birth weight between
the two groups.[ 2.1 (1.5-2.4) vs 3.3 (3.0-3.8) kg, p¼ 0.001)].
The distributions of age, gender, fasting glucose, Total cholesterol, triglyceride, low
density lipoprotein cholesterol, high density lipoprotein cholesterol, Ca++, Magne-
sium, C-reactive protein (CRP), hemoglobin, serum insulin concentration, HOMA and
serum creatinin values were similar in both groups(Table 1).
Compared with the NBW group, the LBW group had lower FMD (%) (6.682.1
vs 7.81.9, p<0.004) (Figure 1) and similar cIMT (p>0.05) (Table 2). There
was a negative linear relation between waist circumference and ﬂow -mediated
low-mediated dilatation is shown on scatter diagram. (r ¼-0.521, p<0.001)
(Figure 2). The presence of LBW was affecting to FMD (b  SE: -0.0280.01,
p¼0.004), and waist circumference was related with cIMT and FMD (bSE ¼
0.0040.0001, p<0.001 and bSE¼0.070.002, p<0.001,respectively. (Table 3).
Conclusions: The children with LBW are potentially at risk for early atherosclerosis
because LBW closely affects to FMD, even though but not cIMT. The cIMT and FMD
are also related to the waist circumference.C38 JACC VVariables n ¼68 n¼60 *p
Systolic blood pressure, mmHg 10711 10910 0.312
Diastolic blood pressure, mmHg 726 708 0.171
Right CCADD, mm 6.240.32 6.330.28 0.284
Left CCADD, mm 6.230.35 6.290.27 0.141
Right cIMT, mm 0.46 0.09 0.47 0.08 0.164
Left cIMT, mm 0.45 0.08 0.470.07 0.302
BA baseline diameter, mm 2.840.21 2.810.19 0.584
BA post dilatation diameter, mm 3.020.19 3.030.18 0.843
Brachial artery FMD % 6.68 2.1 7.8 1.9 0.004
BA¼ brachial artery, CCADD ¼ common carotid artery diastolic diameter, FMD ¼ ﬂow
mediated dilatation, cIMT ¼ carotid intima media thickness, *Student t test
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